Athene Holding Ltd. Issues Regulation FD Disclosure Update
Athene Holding Ltd. files 8-K disclosing Regulation FD updates, emphasizing transparency in the life insurance sector.
Arbor Realty Trust releases investor presentation update
Arbor Realty Trust shares insights through an investor presentation, emphasizing transparency and strategic direction in the real estate investment trust sector.
Starwood Real Estate Income Trust Reports Recent Developments
Starwood Real Estate Income Trust, Inc. files 8-K detailing recent developments, highlighting transparency and regulatory compliance in the real estate investment trust sector.
LCI Industries affirms merger with Patrick, rejects rival bid
LCI Industries confirms merger with Patrick Industries, dismissing Monomoy Capital's proposal, signaling strategic commitment in the motor vehicle parts sector.
Fidelity Investments Variable Annuity Account I Updates Prospectus
Fidelity Investments Variable Annuity Account I updates its summary prospectus, reflecting changes in current expenses for its investment portfolios.
OAK RIDGE INVESTMENTS LLC Reports $1.68 Billion in Holdings
OAK RIDGE INVESTMENTS LLC files 13F-HR, revealing $1.68 billion in holdings as of September 30, 2026, highlighting significant investments in top companies.
Fidelity Investments Variable Annuity Account I Updates Prospectus
Fidelity Investments Variable Annuity Account I updates its prospectus, effective November 1, 2026, enhancing transparency on investment expenses.
Federated Hermes Adviser Series Reports Sales and Redemptions
Federated Hermes Adviser Series discloses sales of $29.97 million and redemptions of $121.8 million in recent SEC filing.
Fidelity Investments Variable Annuity Account I Updates Portfolio
Fidelity Investments Variable Annuity Account I announces updates to its investment portfolio and expenses, effective November 1, 2026.
Harmony Gold Mining Co. Reports Annual Results for 2026
Harmony Gold Mining Co. Ltd. releases its annual report for FY 2026, showcasing financial performance and strategies in the gold and silver ores sector.
McKesson Corp's 1.625% Notes to Be Removed from NYSE
McKesson Corp's 1.625% Notes due 2026 will be removed from the NYSE effective November 10, 2026, following their redemption on October 30.
GameStop warrants to be removed from NYSE listing
GameStop Corp. warrants will be delisted from NYSE due to changes in underlying securities, impacting trading and investor strategies.
BadgerMax Partners amends hedge fund offering details
BadgerMax Partners, LP - Series B has amended its hedge fund offering, reflecting ongoing trends in the investment fund sector.
Appleton Partners reports $1.63 million in holdings in 13F
Appleton Partners Inc. discloses $1.63 million in holdings as of September 30, 2026, in its latest 13F-HR filing, highlighting key investments in major companies.
OP Asset Management files N-PX report on executive compensation votes
OP Asset Management Ltd's recent N-PX filing reveals its voting decisions on executive compensation, highlighting its commitment to transparency in investment practices.
MDI Pilot Point Net Lease DST Files New Offering to Raise $6.24M
MDI Pilot Point Net Lease DST seeks to raise $6.24 million through a new offering, emphasizing interest in commercial real estate investments.
Truist Bank files 13F-NT report, signals investment changes
Truist Bank files a 13F-NT report, indicating a shift in its investment strategy as of September 30, 2026, impacting the financial services industry.
HomesToLife Ltd Changes CFO Services Provider to Subsidiary
HomesToLife Ltd transitions CFO services from HTL Furniture to HomesToLife US, ensuring leadership continuity amidst industry changes.
Cohen & Steers reports strong Q3 results with revenue growth
Cohen & Steers, Inc. announces significant growth in Q3 revenue and net income, strengthening its position in the investment advice industry.
Moleculin Biotech Completes Dosing in Pivotal MIRACLE Trial
Moleculin Biotech completes dosing in its pivotal MIRACLE trial for Annamycin, aiming to improve treatment for acute myeloid leukemia. Data expected in Q1 2027.